MedPath

A study to investigate the Efficacy, Safety, Acceptability of Essilor® Stellest® Spectacle Lenses along with the testing of Quality of Life implications in slowing down Myopia progression, in children and adolescents in India.

Not Applicable
Conditions
Health Condition 1: H521- Myopia
Registration Number
CTRI/2024/08/071994
Lead Sponsor
Essilor® India Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Inclusion should be progressive myopia based on change in RE in the previous year

2. Information on progression of myopia prior to treatment should be available

3. All participants wearing Essilor® Stellest® Lenses

Exclusion Criteria

Not Applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare with change in SER over 1 year prior to use of Stellest lenses and Change in cycloplegic autorefraction (SER) from baseline upto 12 monthsTimepoint: Up to 12 months
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath